12.37
Finanzdaten der Angiodynamic Inc-Aktie (ANGO)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-08-31 | 2026-05-31 | 2026-02-28 | 2025-11-30 | 2025-08-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
6.57%
80.92
|
86.61 | 78.42 | 79.43 | 75.71 |
| Cost Of Revenue |
17.47%
32.88
|
39.83 | 36.94 | 34.65 | 33.85 |
| Gross Profit |
2.71%
48.04
|
46.77 | 41.48 | 44.78 | 41.86 |
| Operating Expenses |
2.85%
55.34
|
56.97 | 54.43 | 50.91 | 52.51 |
| Depreciation and Amortization |
1.77%
5.498
|
5.597 | 5.591 | 5.747 | 6.02 |
| Operating Income/Loss |
28.38%
-7.302
|
-10.20 | -12.95 | -6.125 | -10.66 |
| Nonoperating Income/Loss |
0.006
|
- | 4.879 | -0.23 | -0.182 |
| Income/Loss From Continuing Operations Before Tax |
33.88%
-7.296
|
-11.04 | -8.072 | -6.355 | -10.84 |
| Income Tax Expense/Benefit, Deferred |
304.00%
-0.306
|
0.15 | 0.057 | -0.048 | -0.016 |
| Income Tax Expense/Benefit |
153.78%
-0.199
|
0.37 | 0.012 | -0.005 | 0.065 |
| Net Income/Loss |
37.77%
-7.097
|
-11.40 | -8.084 | -6.35 | -10.90 |
| Basic Average Shares |
42.02
|
- | 41.60 | 41.54 | 41.17 |
| Diluted Average Shares |
42.02
|
- | 41.60 | 41.54 | 41.17 |
| Basic Earnings Per Share |
-0.17
|
- | -0.19 | -0.15 | -0.26 |
| Diluted Earnings Per Share |
-0.17
|
- | -0.19 | -0.15 | -0.26 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):